Camena Bioscience is a synthetic biology company that is pioneering enzymatic DNA synthesis. The company's innovative gSynth® platform offers a more accurate, faster, and more sustainable method of "writing" DNA compared to traditional chemical synthesis. This technology is crucial for producing complex and long DNA sequences, which are essential for developing next-generation therapeutics and various synthetic biology applications. Constructive Bio, also located in Cambridge, is a synthetic genomics company that specializes in whole genome writing and genetic code reprogramming. By leveraging its expertise in large-scale DNA assembly and advanced platforms, the company aims to turn living cells into "biofactories" capable of producing novel biomolecules, sustainable materials, and therapeutics that were previously impossible to create.